Please provide your email address to receive an email when new articles are posted on . Data from SURMOUNT-OSA and a prespecified analysis of the SELECT trial were among the biggest obesity studies in ...
While outcomes were somewhat attenuated in elderly patients, benefits were consistent across sex and age. These findings ...
Researchers projected that adult obesity rates in the U.S. will rise to 47% in the next decade. Women under age 35 had the largest increase in obesity prevalence from 1990 to 2022. Multifactorial ...
Add Yahoo as a preferred source to see more of our stories on Google. It’s Tuesday morning and you’ve just washed your third Danish down with your fourth cup of coffee. Sound familiar? If so, there is ...
Hosted on MSN
ARWR: Encouraging early data for obesity programs
On January 6, 2026, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced preliminary results for the company’s investigational treatments for obesity, ARO-INHBE and ARO-ALK7. The company also held ...
The disturbing statistics on childhood obesity in New Mexico should serve as a wake-up call to unite parents, public health experts, educators, doctors, lawmakers and farmers in a coordinated effort ...
Biohaven Ltd. downgraded after FDA CRL for troriluzole; see its pipeline shift to obesity/neurology, Phase 2 catalysts, and ...
Obesity is linked to increased cancer risk through inflammation, metabolic dysfunction, and immune changes. Dr. Jennifer ...
VK2735 shows strong early weight-loss data, positioning Viking as a potential third major player in the booming GLP-1 obesity drug market. Despite a sharp stock decline, Viking is well-funded, with ...
Roughly 126 million U.S. adults ages 20 and older are projected to have obesity by 2035, according to estimates from a cross-sectional analysis. In 1990, 19.3% of U.S. adults had obesity; in 2022, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results